FDA approves Skyrizi (risankizumab-rzaa) to treat Crohn’s disease | Carrick Pharmacy
(Carrick Pharmacy News) There’s a new treatment for Crohn’s disease. It’s called Skyrizi (risankizumab-rzaa). The US Food and Drug Administration (FDA) approved it to treat moderate to severe Crohn’s disease in adults. This medication is an anti-interleukin 23 (IL-23) monoclonal antibody. It’s the first of its kind to be approved for the treatment of Crohn’s …
FDA approves Skyrizi (risankizumab-rzaa) to treat Crohn’s disease | Carrick Pharmacy Read More »
